ABSTRACT
Polyphenols
are
secondary
metabolites
produced
by
a
large
variety
of
plants.
These
compounds
that
comprise
the
class
phenolic
acids,
stilbenes,
lignans,
coumarins,
flavonoids,
and
tannins
have
wide
range
employment,
from
food
production
to
medical
usages.
Among
beneficial
applications
polyphenols,
their
antiviral
activity
is
gaining
importance
due
increased
prevalence
drug‐resistant
viruses
such
as
herpes
hepatitis
B
viruses.
In
present
review,
we
provide
an
overview
most
promising
or
commonly
used
polyphenols
mechanisms
action
focusing
on
effects
enveloped
clinical
(double‐stranded
linear
partially
double‐stranded
circular
DNA
viruses,
negative
sense
single‐stranded
RNA
with
nonsegmented
segmented
genomes,
positive
viruses).
The
work
emphasizes
relevance
in
particular
epigallocatechin‐3‐gallate
resveratrol,
alternative
supportive
antivirals.
could
interfere
virtually
all
steps
viral
infection,
adsorption
release
particles.
against
especially
relevant
given
risk
widespread
outbreaks
associated
remarked
recent
COVID‐19
pandemic.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(9), P. 1690 - 1690
Published: Aug. 29, 2022
The
formation
of
microthrombi
in
lung
autopsies
indicates
the
involvement
NETs
immunopathogenesis
severe
COVID-19.
Therefore,
supplements
inhibiting
NET
formation,
association
with
drugs
fewer
adverse
effects,
should
be
a
relevant
strategy
to
attenuate
disease.
Resveratrol
(RESV)
is
natural
polyphenol
an
important
antiviral
and
antioxidant
role.
To
modulate
neutrophils
from
patients
infected
SARS-CoV-2,
we
evaluated
vitro
effect
RESV
on
formation.
Herein,
investigated
190
hospitalized
moderate,
severe,
critical
symptoms
at
Hospital
das
Clínicas,
Brazil.
We
observed
that
neutrophilia
COVID-19
infection
composed
activated
profile
able
release
spontaneously.
Notably,
decreased
neutrophil-activated
status
free
DNA,
even
under
specific
PMA
stimulus.
At
present,
there
no
evidence
role
infection.
These
findings
suggest
adjunctive
therapies
may
help
decrease
inflammation
viral
or
bacterial
infection,
improving
patient
outcomes.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(11), P. 9589 - 9589
Published: May 31, 2023
Despite
the
fact
that
coronavirus
disease
2019
(COVID-19)
treatment
and
management
are
now
considerably
regulated,
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
is
still
one
of
leading
causes
death
in
2022.
The
availability
COVID-19
vaccines,
FDA-approved
antivirals,
monoclonal
antibodies
low-income
countries
poses
an
issue
to
be
addressed.
Natural
products,
particularly
traditional
Chinese
medicines
(TCMs)
medicinal
plant
extracts
(or
their
active
component),
have
challenged
dominance
drug
repurposing
synthetic
compound
libraries
therapeutics.
Their
abundant
resources
excellent
antiviral
performance
make
natural
products
a
relatively
cheap
readily
available
alternative
for
Here,
we
deliberately
review
anti-SARS-CoV-2
mechanisms
potency
(pharmacological
profiles),
application
strategies
intervention.
In
light
advantages,
this
intended
acknowledge
potential
as
therapeutic
candidates.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(6), P. 2470 - 2470
Published: March 8, 2023
Natural
products
and
plant
extracts
exhibit
many
biological
activities,
including
that
related
to
the
defense
mechanisms
against
parasites.
Many
studies
have
investigated
functions
of
secondary
metabolites
reported
evidence
antiviral
activities.
The
pandemic
emergencies
further
increased
interest
in
finding
agents,
efforts
are
oriented
investigate
possible
activities
human
viruses
their
potential
application
treating
or
preventing
SARS-CoV-2
infection.
In
this
review,
we
performed
a
comprehensive
analysis
through
silico
vitro
investigations,
also
vivo
applications
clinical
trials,
evaluate
state
knowledge
on
infection,
with
particular
focus
natural
compounds
present
food
plants.
Although
some
seem
be
useful
prevention
as
therapeutic
management
SARS-CoV-2,
up
now,
no
molecules
can
used
treatment
for
COVID-19;
however,
more
research
is
needed.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 10, 2024
Lytic
bacteriophages,
viruses
that
lyse
(kill)
bacteria,
hold
great
promise
for
treating
infections,
including
wound
infections
caused
by
antimicrobial-resistant
Clinical Epigenetics,
Journal Year:
2021,
Volume and Issue:
13(1)
Published: Oct. 11, 2021
SARS-CoV-2
uses
the
angiotensin-converting
enzyme
2
(ACE2)
and
neuropilin-1
(NRP1)
receptors
for
entry
into
cells,
serine
protease
TMPRSS2
S
protein
priming.
Inhibition
of
activity
or
engagement
with
ACE2
NRP1
has
been
shown
to
be
an
effective
strategy
blocking
infectivity
viral
spreading.
Valproic
acid
(VPA;
2-propylpentanoic
acid)
is
epigenetic
drug
approved
clinical
use.
It
produces
potent
antiviral
anti-inflammatory
effects
through
its
function
as
a
histone
deacetylase
(HDAC)
inhibitor.
Here,
we
propose
VPA
potential
candidate
tackle
COVID-19,
in
which
rapid
spread
replication,
hyperinflammation
are
crucial
elements.We
used
diverse
cell
lines
(HK-2,
Huh-7,
HUVEC,
Caco-2,
BEAS-2B)
analyze
effect
other
HDAC
inhibitors
on
expression
ACE-2
NRP-1
their
ability
inhibit
infectivity,
production,
inflammatory
response.
Treatment
significantly
reduced
host
proteins
all
mechanism
mediated
by
inhibitory
activity.
The
maintained
after
infection.
Consequently,
treatment
cells
before
infection
impairs
production
infectious
viruses,
but
not
that
ACE2-
NRP1-independent
viruses
(VSV
HCoV-229E).
Moreover,
addition
1
h
post-infection
reduces
dose-dependent
manner
without
modifying
genomic
subgenomic
messenger
RNAs
(gRNA
sg
mRNAs)
levels
N
protein.
cytokines
(TNF-α
IL-6)
induced
TNF-α
diminished
presence
VPA.Our
data
showed
blocks
three
essential
processes
determining
severity
COVID-19.
downregulates
NRP1,
reducing
SARS-CoV-2;
it
decreases
yields,
probably
because
affects
virus
budding
virions
stability;
dampens
triggered
Thus,
administering
could
considered
safe
COVID-19
patients
until
vaccines
have
rolled
out
across
world.
Food Innovation and Advances,
Journal Year:
2023,
Volume and Issue:
2(1), P. 44 - 59
Published: Jan. 1, 2023
COVID-19,
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
is
a
major
public
health
threat.
Edible
plants
are
rich
in
bioactive
components,
with
variety
of
functions,
such
as
enhancing
immunity,
antiviral,
anti-inflammatory
and
so
on.
Thus,
the
intake
edible
to
boost
body's
resistance
COVID-19
promising
possibly
affordable
strategy.
This
review
revisits
effects
functional
components
from
(such
polyphenols,
polysaccharides,
lectin,
alkaloids,
polyunsaturated
fatty
acids,
terpenoids,
saponins)
on
COVID-19.
The
inhibitory
virus's
entrance
replication,
immune
enhancement
discussed.
And
finally,
we
present
prospects
using
plant
ingredients
vaccine
adjuvants
problems
use
for
prevention
Functional
interacted
structural
proteins
SARS-CoV-2
virus
key
enzymes
recognition
thereby
inhibiting
entry
replication
host.
Meanwhile,
these
had
could
inhibit
cytokine
storms.
Therefore,
believe
that
can
enhance
human
be
applied
development
new
therapies.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(11), P. 2639 - 2639
Published: June 5, 2023
Over
the
last
few
years,
we
have
experienced
infection
generated
by
severe
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
often
resulting
in
an
exaggerated
immune
reaction
and
systemic
inflammation.
The
preferred
treatments
against
SARS-CoV-2
were
those
that
mitigated
immunological/inflammatory
dysfunction.
A
variety
of
observational
epidemiological
studies
reported
vitamin
D
deficiency
is
a
crucial
factor
many
inflammatory
diseases
autoimmune
diseases,
as
well
susceptibility
to
contract
infectious
including
acute
infections.
Similarly,
resveratrol
regulates
immunity,
modifying
gene
expression
release
proinflammatory
cytokines
cells.
Therefore,
it
plays
immunomodulatory
role
can
be
beneficial
prevention
development
non-communicable
associated
with
Since
both
also
act
immunomodulators
pathologies,
paid
particular
attention
integrated
treatment
either
or
This
article
offers
critical
evaluation
published
clinical
trials
examined
use
adjuncts
COVID-19
management.
Furthermore,
aimed
compare
anti-inflammatory
antioxidant
properties
linked
modulation
system,
along
antiviral
resveratrol.
PeerJ,
Journal Year:
2023,
Volume and Issue:
11, P. e14915 - e14915
Published: March 14, 2023
Coronavirus
disease
2019
(COVID-19)
is
a
global
pandemic
infecting
the
respiratory
system
through
notorious
virus
known
as
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2).
Due
to
viral
mutations
and
risk
of
drug
resistance,
it
crucial
identify
new
molecules
having
potential
prophylactic
or
therapeutic
effect
against
SARS-CoV-2
infection.
In
present
study,
we
aimed
inhibitor
virtual
screening
compound
library
470
quercetin
derivatives
by
targeting
main
protease—Mpro
(PDB
ID:
6LU7).
The
study
was
carried
out
with
computational
techniques
such
molecular
docking
simulation
studies
(MDSS),
dynamics
(MD)
simulations,
mechanics
generalized
Born
surface
area
(MMGBSA)
techniques.
Among
natural
derivatives,
382
(PubChem
CID
65604)
showed
best
binding
affinity
Mpro
(−11.1
kcal/mol).
Compound
interacted
LYS5,
TYR126,
GLN127,
LYS137,
ASP289,
PHE291,
ARG131,
SER139,
GLU288,
GLU290
protein.
Mpro-382
complex
acceptable
stability
during
100
ns
MD
simulations.
also
an
MM-GBSA
free
energy
value
-54.0
kcal/mol.
affinity,
stability,
results
for
were
better
than
those
native
ligand
standard
inhibitors
ledipasvir
cobicistat.
conclusion
our
that
has
inhibit
SARS-Cov-2
Mpro.
However,
further
investigations
in-vitro
assays
are
recommended
confirm
its
in-silico
potency.
Virology Journal,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Jan. 4, 2024
Abstract
Chikungunya
virus
(CHIKV)
infection
causes
chikungunya,
a
viral
disease
that
currently
has
no
specific
antiviral
treatment.
Several
repurposed
drug
candidates
have
been
investigated
for
the
treatment
of
disease.
In
order
to
improve
efficacy
known
drugs,
combining
drugs
is
promising
approach.
The
current
study
was
undertaken
explore
activity
combination
were
reported
anti-CHIKV
activity.
We
explored
effect
different
combinations
six
effective
(2-fluoroadenine,
emetine,
lomibuvir,
enalaprilat,
metyrapone
and
resveratrol)
at
their
non-toxic
concentrations
against
CHIKV
under
post
conditions
in
Vero
cells.
Focus-forming
unit
assay,
real
time
RT-PCR,
immunofluorescence
western
blot
used
determine
titre.
results
revealed
2-fluoroadenine
with
either
or
emetine
enalaprilat
exerted
inhibitory
post-infection
conditions.
these
additive
nature
compared
individual
drugs.
suggest
an
anti-viral
CHIKV.
findings
could
serve
as
outline
development
innovative
therapeutic
approach
future
treat
CHIKV-infected
patients.